Neuralstem Reports First Quarter 2019 Fiscal Results

Wednesday, May 15, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

- Kenneth C. Carter, PhD appointed Executive Chairman

Neuralstem, Inc.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

Three Months Ended March 31,

2019

2018

Revenues

$                              2,500

$                      2,500

Operating expenses:

Research and development expenses

1,514,463

1,169,441

General and administrative expenses

944,602

1,182,054

Total operating expenses

2,459,065

2,351,495

Operating loss

(2,456,565)

(2,348,995)

Other income (expense):

Interest income

29,000

17,749

Interest expense

(2,017)

(1,920)

Change in fair value of derivative instruments

(340,115)

190,219

Other income (expense)

(344,295)

(4,021)

Total other income (expense)

(657,427)

202,027

Net loss

$                      (3,113,992)

$             (2,146,968)

Net loss per share - basic and diluted

$                               (0.17)

$                      (0.14)

Weighted average common shares outstanding - basic

18,216,421

15,116,937

Comprehensive loss:

Net loss

$                      (3,113,992)

$             (2,146,968)

Foreign currency translation adjustment

(1,743)

115

Comprehensive loss

$                      (3,115,735)

$             (2,146,853)



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store